169 related articles for article (PubMed ID: 10708452)
21. Effects of combined treatment with CD25- and CD154-specific monoclonal antibodies in non-human primate allotransplantation.
Xu H; Elster EA; Blair PJ; Burkly LC; Tadaki DK; Harlan DM; Kirk AD
Am J Transplant; 2003 Nov; 3(11):1350-4. PubMed ID: 14525594
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of T cell activation by immobilized hu5C8 (anti-CD40L) monoclonal antibody.
Arpinati M; Chirumbolo G; Rondelli D
Eur J Haematol; 2008 Apr; 80(4):322-30. PubMed ID: 18081708
[TBL] [Abstract][Full Text] [Related]
23. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
Hirohata S
Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
[TBL] [Abstract][Full Text] [Related]
24. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.
Kuzmin AI; Galenko O; Eisensmith RC
Mol Ther; 2001 Mar; 3(3):293-301. PubMed ID: 11273770
[TBL] [Abstract][Full Text] [Related]
25. Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs.
Chirmule N; Hughes JV; Gao GP; Raper SE; Wilson JM
J Virol; 1998 Jul; 72(7):6138-45. PubMed ID: 9621078
[TBL] [Abstract][Full Text] [Related]
26. Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates.
Wilmott RW; Amin RS; Perez CR; Wert SE; Keller G; Boivin GP; Hirsch R; De Inocencio J; Lu P; Reising SF; Yei S; Whitsett JA; Trapnell BC
Hum Gene Ther; 1996 Feb; 7(3):301-18. PubMed ID: 8835218
[TBL] [Abstract][Full Text] [Related]
27. Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells.
Kikuchi T; Crystal RG
Hum Gene Ther; 1999 May; 10(8):1375-87. PubMed ID: 10365667
[TBL] [Abstract][Full Text] [Related]
28. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells.
Wykes M; Poudrier J; Lindstedt R; Gray D
Eur J Immunol; 1998 Feb; 28(2):548-59. PubMed ID: 9521065
[TBL] [Abstract][Full Text] [Related]
29. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.
Gerritse K; Laman JD; Noelle RJ; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2499-504. PubMed ID: 8637903
[TBL] [Abstract][Full Text] [Related]
30. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.
Yang Y; Trinchieri G; Wilson JM
Nat Med; 1995 Sep; 1(9):890-3. PubMed ID: 7585213
[TBL] [Abstract][Full Text] [Related]
31. Biology of E1-deleted adenovirus vectors in nonhuman primate muscle.
Zoltick PW; Chirmule N; Schnell MA; Gao GP; Hughes JV; Wilson JM
J Virol; 2001 Jun; 75(11):5222-9. PubMed ID: 11333904
[TBL] [Abstract][Full Text] [Related]
32. Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression.
Cao H; Yang T; Li XF; Wu J; Duan C; Coates AL; Hu J
Gene Ther; 2011 Feb; 18(2):173-81. PubMed ID: 20882053
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of tumoricidal activity of alveolar macrophages via CD40-CD40 ligand interaction.
Imaizumi K; Kawabe T; Ichiyama S; Kikutani H; Yagita H; Shimokata K; Hasegawa Y
Am J Physiol; 1999 Jul; 277(1):L49-57. PubMed ID: 10409230
[TBL] [Abstract][Full Text] [Related]
34. Long-term survival of xenografted neonatal cardiomyocytes by adenovirus-mediated CTLA4-Ig expression and CD40 blockade.
Li TS; Ito H; Kajiwara K; Hamano K
Circulation; 2003 Oct; 108(14):1760-5. PubMed ID: 14504180
[TBL] [Abstract][Full Text] [Related]
35. Local high-capacity adenovirus-mediated mCTLA4Ig and mCD40Ig expression prolongs recombinant gene expression in skeletal muscle.
Jiang ZL; Reay D; Kreppel F; Gambotto A; Feingold E; Kochanek S; McCarthy SA; Clemens PR
Mol Ther; 2001 Jun; 3(6):892-900. PubMed ID: 11407903
[TBL] [Abstract][Full Text] [Related]
36. IL-12 reverses the suppressive effect of the CD40 ligand blockade on experimental autoimmune encephalomyelitis (EAE).
Constantinescu CS; Hilliard B; Wysocka M; Ventura ES; Bhopale MK; Trinchieri G; Rostami AM
J Neurol Sci; 1999 Dec; 171(1):60-4. PubMed ID: 10567051
[TBL] [Abstract][Full Text] [Related]
37. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of CD40 ligand (CD154) in the treatment of factor VIII inhibitors.
Ewenstein BM; Hoots WK; Lusher JM; DiMichele D; White GC; Adelman B; Nadeau K
Haematologica; 2000 Oct; 85(10 Suppl):35-9. PubMed ID: 11187868
[TBL] [Abstract][Full Text] [Related]
39. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.
Jooss K; Turka LA; Wilson JM
Gene Ther; 1998 Mar; 5(3):309-19. PubMed ID: 9614550
[TBL] [Abstract][Full Text] [Related]
40. In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity.
Sun Y; Peng D; Lecanda J; Schmitz V; Barajas M; Qian C; Prieto J
Gene Ther; 2000 Sep; 7(17):1467-76. PubMed ID: 11001366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
